Diatech Pharmacogenetics Announces New Collaboration to Advance Precision Testing in Oncology

Diatech Pharmacogenetics (“Diatech”) has established a collaboration agreement with Janssen Pharmaceutica NV with the aim of improving access t...

June 21, 2023 | Wednesday | News
FDA Pilot Program Aims to Reduce Risks of Cancer Biomarker Tests

U.S. Food and Drug Administration announced a new voluntary pilot program for certain oncology drug products used with certain corresponding in vitro diagn...

June 21, 2023 | Wednesday | News
FDA Approves New Class of Medicines to Treat Pediatric Type 2 Diabetes

"Compared to adults, children with type 2 diabetes have limited treatment options, even though the disease and symptom onset generally progress more rapidl...

June 21, 2023 | Wednesday | News
Emgality Shows Promising Results in Landmark Migraine Prevention Trial, Says Eli Lilly Study

Emgality demonstrated robust efficacy for patients consistent with previous studies, although it did not achieve statistical superiority versus active comp...

June 17, 2023 | Saturday | News
QIAGEN's QuantiFERON-TB Gold Plus Shows Unique Clinical Benefits in Tuberculosis Screenings

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) welcomes the publication of a new systematic evaluation that underlines the unique benefits of the compa...

June 16, 2023 | Friday | News
Senju Pharma and Novaliq Sign License Agreement for NOV03 Dry Eye Treatment in Japan

"We are very pleased about the cooperation with Novaliq, a pioneer for groundbreaking non-aqueous eye drop technology. With regard to the unique properties...

June 14, 2023 | Wednesday | News
ACROBiosystems Aneuro Teams Up with Diagnostic Biochips for Neuroscience Drug Discovery

Electrophysiology is a critical part of neuroscience research, especially when attempting to elucidate the neural network. Monitoring the brain's field pot...

June 14, 2023 | Wednesday | News
Increased Demand for ABA Therapy Requires Precision Treatment Planning to Achieve Timely Access to Care

According to a recent report by the Centers for Disease Control and Prevention (CDC), 1 in 36 children in the U.S. is diagnosed with an autism spectrum dis...

June 13, 2023 | Tuesday | News
Myriad Genetics Announces Research Collaboration to use Minimal Residual Disease Testing Platform

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced an agreement with The University of Texas MD And...

June 13, 2023 | Tuesday | News
BoomerangFX and DrFirst Partner for E-Prescribing in Aesthetic Medicine Practices in North America

BoomerangFX, an international cloud-based SaaS provider of end-to-end practice management solutions for non-insured, private-pay healthcare segments includ...

June 08, 2023 | Thursday | News
PathomIQ and Neuberg Diagnostics Collaborate on AI-based Biomarker Tests for Clinical Use

PathomIQ is a leading provider of AI-enabled tools for prostate, breast, lung and other cancers that enable precision medicine by extracting yet untapped i...

June 07, 2023 | Wednesday | News
Janssen Seeks FDA Approval for CARVYKTI® in Early Treatment of Multiple Myeloma

Application is supported by data from the Phase 3 CARTITUDE-4 study, which showed significant improvement in primary endpoint of progre...

June 07, 2023 | Wednesday | News
New Coalition Launched to Fight Breast and Cervical Cancers Across Asia-Pacific

 Crowell & Moring International is joining forces with Roche, TogetHER for Health, CAPED and Jhpiego to raise awareness about the surge of br...

June 02, 2023 | Friday | News
New CapnoPen® CP-001k receives CE certification (MDR)

Stéphane Rohan Laurent, Capnopharm’s VP Sales & Business Development, comments: “Receiving CE certification constitutes a landm...

May 31, 2023 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close